Michael Atkin

Chief Executive Officer at

Ulysses Pharmaceuticals Products, Inc.

70 year

Health Technology

Consumer Services

Profile

Michael C.
Atkin is the founder of Syzent Partners Ltd. founded in 2008, where he holds the title of President.
He currently holds the positions of Executive Chairman, President & CEO at Ulysses Pharmaceuticals Products, Inc. and Director at Affinite Instruments.
Mr. Atkin's former positions include President & Chief Executive Officer at Aegera Therapeutics, Inc., President, Chief Executive Officer & Secretary at Gladius Pharmaceuticals Corp., Chairman at ChitogenX, Inc., Chairman at Sopharmia, Inc., Director at Genizon Biosciences, Inc., Director at Topigen Pharmaceuticals, Inc., and Principal at Bristol Myers Squibb Co. He also held the position of Vice President-Business Development at Lederle International.
Mr. Atkin received his undergraduate degree from the University of Kent and his MBA from Columbia Business School.

Michael Atkin active positions

Companies	Position	Start
Ulysses Pharmaceuticals Products, Inc. Ulysses Pharmaceuticals Products, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antibiotics for empiric monotherapy to control resistant bacterial infections	Chief Executive Officer	-
Syzent Partners Ltd.	Founder	01/01/2008
Affinite Instruments	Director/Board Member	-

All active positions of Michael Atkin

Former positions of Michael Atkin

Companies	Position	End
CHITOGENX INC.	Chairman	01/07/2022
Gladius Pharmaceuticals Corp. Gladius Pharmaceuticals Corp. BiotechnologyHealth Technology Operates as biotechnology firm	Chief Executive Officer	01/01/2019
Genizon Biosciences, Inc. Genizon Biosciences, Inc. BiotechnologyHealth Technology Provides drug development services	Director/Board Member	30/05/2012
Sopharmia, Inc.	Chairman	-
Lederle International	Corporate Officer/Principal	-

See the detail of Michael Atkin's experience

Training of Michael Atkin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Atkin's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	13
Bristol Myers Squibb Co. Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products	Health Technology
Genizon Biosciences, Inc. Genizon Biosciences, Inc. BiotechnologyHealth Technology Provides drug development services	Health Technology
Aegera Therapeutics, Inc. Aegera Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and develops drugs	Health Technology
Topigen Pharmaceuticals, Inc. Topigen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for respiratory diseases	Health Technology
Lederle International
Ulysses Pharmaceuticals Products, Inc. Ulysses Pharmaceuticals Products, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antibiotics for empiric monotherapy to control resistant bacterial infections	Health Technology
University of Kent University of Kent Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Columbia Business School Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Gladius Pharmaceuticals Corp. Gladius Pharmaceuticals Corp. BiotechnologyHealth Technology Operates as biotechnology firm	Health Technology
ChitogenX, Inc. ChitogenX, Inc. BiotechnologyHealth Technology Operates as a development stage biotechnology company	Health Technology
Syzent Partners Ltd.
Sopharmia, Inc.
Affinite Instruments